课题基金 / 基金详情

STRUCTURAL BIOLOGY OF SIGNALING AND THE ACTIN CYTOSKELETON

STRUCTURAL BIOLOGY OF SIGNALING AND THE ACTIN CYTOSKELETON
信号传导和肌动蛋白细胞骨架的结构生物学
批准号:
7955079
负责人:
MICHAEL J ECK
金额:
$7.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2010-03-31

项目摘要

项目成果

MICHAEL J ECK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Our subproject focuses in two inter-related areas  tyrosine kinases and formin family proteins and their regulators. We are working to understand the structure and regulation of tyrosine kinases, especially those that are dysregulated in cancer or are targets for anti-cancer drugs. We are studying focal adhesion kinase (FAK) in order to understand how it is regulated and to facilitate development of FAK-specific inhibitors. We are studying Jak-family kinases in order to understand their mechanism of association with cytokine receptors, how they are regulated by intramolecular interactions and how this regulation is disrupted in hematoproliferative disorders (such as polycythemia vera) in which Jak2 or Jak3 is mutated. Through our studies of the structure of EGFR kinase mutants, we hope elucidate mechanisms of oncogenic activation and drug resistance, and also to design inhibitors that are mutant-specific for use in the treatment of lung and other cancers that arise from EGFR mutations. In our investigations of formin proteins such as Daam1, mDia, and Bni1 we hope to learn how these molecules are regulated and how they function in actin assembly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma
  • 批准号:
    10306230
  • 项目类别:
  • 资助金额:
    $19.62万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL J ECK
  • 依托单位:
Small molecule inhibitors with a therapeutic window for EGFR signaling variants in glioblastoma
  • 批准号:
    10491835
  • 项目类别:
  • 资助金额:
    $17.78万
  • 财政年份:
    2021
  • 负责人:
    MICHAEL J ECK
  • 依托单位:
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
  • 批准号:
    9816771
  • 项目类别:
  • 资助金额:
    $106.8万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL J ECK
  • 依托单位:
Structure, mechanism, and pharmacology of BRAF and its partners in the RAS/RAF/MAP kinase pathway
  • 批准号:
    10669154
  • 项目类别:
  • 资助金额:
    $104.66万
  • 财政年份:
    2019
  • 负责人:
    MICHAEL J ECK
  • 依托单位:
海外基金